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229）、 ALP412U/L（基準値：ll5-359）、 CA125 36U 



















































































































1 P百rkら＼7) 23 IC 
2 Vicusら（乙） 16 IA 














4 Kasendaら｛ヨl 26 IA ＋媛篠生検÷虫垂 完全 なし
切絵＋大絹切除



















NA: not available, USO: unilateral salpingo-oopherectomy, LOC: left ovarian cystectomy, LSO: left 
salpingo-oopherectomy, ROC: right ovarian cystectomy, RSO: right salpingo-oopherectomy, PLA: pelvic 
lymphadenectomy, PALA: para aortic lymphadenectomy, BEP= bleomycin十 etoposide+platinum, EP= 
etoposide+ platinum, NED: no evidence of desease 
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